An antibody that targets and is taken up only by certain types of cancer cells has been developed by A*STAR researchers. Combining this antibody with an anticancer drug could lead to a new treatment for some types of breast ...
Jan 15, 2019
0
13
After a flesh wound, skin cells march forward to close the gap and repair the injury. Findings from a team led by Leah Vardy at A*STAR's Skin Research Institute of Singapore now demonstrate how a carefully regulated set of ...
Jan 15, 2019
0
0
White blood cells, also known as monocytes, play a key role in the immune system's response to infection. They have been shown to fuse and form multinucleated giant cells (MGCs) during inflammatory reactions, or in response ...
Jan 15, 2019
0
0
Scientists from A*STAR's Singapore Immunology Network (SIgN) and clinicians from Singapore's National University Hospital (NUH) have found that when it comes to influenza vaccinations, healthy elderly individuals are able ...
Dec 20, 2018
0
1
The protein thrombin is vital for ensuring blood coagulates in a wound, but new research suggests small fragments of it, called thrombin-derived C-terminal peptides (TCPs), could also decrease the risk of sepsis in response ...
Dec 20, 2018
0
0
Switching off the enzyme that adds protective caps to chromosome ends could help fight many types of cancer, A*STAR researchers have shown. The team demonstrated the treatment's potential by using it to thwart tumor growth ...
Dec 20, 2018
0
8
Small RNA molecules in saliva could be used to detect the virus that causes hand, foot and mouth disease, enabling early intervention to limit spread of the infection.
Dec 20, 2018
0
1
Not all chronic hepatitis B (HBV) patients require lifelong treatment; but the risks of blindly withdrawing treatment can be severe. However, there's little consensus on which patients can be safely discontinued from treatment, ...
Nov 30, 2018
0
9
A protein crucial for cell division may help to explain why certain cancer therapies are more effective in some patients than others. Genetically altered regulation of this protein has helped A*STAR researchers better understand ...
Nov 30, 2018
0
1
Genome editing technology is helping A*STAR scientists unravel how the Influenza A virus (IAV) exploits human anti-viral responses.
Nov 30, 2018
0
2
